SSelectStock

IKSInventurus Knowledge Solutions Limited

Healthcare · Health Information Services · NSE · as of 2026-09-11 (delayed ~30 min in market hours)

Inventurus Knowledge Solutions Limited operates as a technology-enabled healthcare solutions provider. The company offers a care enablement platform that assists physician businesses in outpatient and inpatient care activities in the United States, Canada, and Australia. The company offers a platform that serves healthcare organizations, including health systems/ integrated delivery networks, academic medical centers, multi-specialty medical groups, single-specialty medical groups, ancillary healthcare organizations, and other outpatient healthcare delivery organizations. Inventurus Knowledge Solutions Limited was incorporated in 2006 and is based in Navi Mumbai, India.

1,740.60
2.42%
67Decent

Mkt Cap
₹29,267 Cr
P/E
41.2
P/B
10.4
Div Yield
0.00%
52W High
₹1,933.00
52W Low
₹1,262.00

Price & Volume

Loading chart…

Key Ratios

Market Cap (₹ cr)29,267.10
P/E41.17
P/B10.42
PEG1.09
ROE %31.44
ROCE %27.20
Debt / Equity0.27
EPS42.28
Revenue Growth %18.50
Profit Growth %38.60
Dividend Yield %0.00
Promoter Holding %73.33
FII Holding %8.99
DII Holding %
Beta0.82

“—” means the figure isn't meaningful or isn't published for this company: ROE and Debt/Equity are undefined when shareholder equity is negative (check P/B — negative means negative equity), and DII/MF holding splits aren't provided by our current data source.

Active Pattern Signals

None of the 16 pattern scanners currently detects a setup on IKS — signals appear here automatically when one forms (checked on every data refresh). The Trade Plan on the right always provides stop-loss and target levels regardless.

HOLDConviction 67%

The picture

  • Revenue growth: 18.5% YoY
  • Profit growth: 38.6% YoY
  • ROE: 31.4%
  • MACD: fresh bullish crossover
  • Price vs SMA200: above
  • Golden cross setup: SMA50 above SMA200

Bull case

  • Revenue growth: 18.5% YoY
  • Profit growth: 38.6% YoY
  • ROE: 31.4%
  • MACD: fresh bullish crossover

Bear case

  • Dividend yield: 0.00%
  • Price vs EMA21: below
  • Price vs SMA50: below
  • 1-month return: -2.3%

Key risks

  • Dividend yield: 0.00%
  • Price vs EMA21: below

Algorithmic analysis for research only — not SEBI-registered investment advice.

Trade Plan

Entry (CMP)
₹1,740.60
Stop Loss
₹1,694.98
risk 2.6%
Target 1 (1.5R)
₹1,809.03
+3.9%
Target 2 (3R)
₹1,877.46
+7.9%
Support (20d)
₹1,712.10
Resistance (52w)
₹1,933.00
Risk : Reward
1 : 1.5 → 1 : 3
risking ₹45.62/share
ATR (volatility)
₹53.29
avg daily range

Stop = 20-day support with a 2.5×ATR risk cap (ATR ₹53.29). Levels recompute on every data refresh. Position sizing and execution are yours — this is analysis, not advice.

Score Breakdown

Fundamental91
Technical44
Momentum63
Risk (safety)75

Peers — Healthcare

GKSL 1.23%
79
NEPHROPLUS 2.42%
74
KOVAI 1.41%
73
SAILIFE 0.38%
73
METROPOLIS 1.70%
73
VIJAYA 0.21%
72